| 000 | 01516 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515000424.0 | ||
| 264 | 0 | _c20060210 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/j.ejphar.2005.07.029 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLambeng, Nathalie | |
| 245 | 0 | 0 |
_aCharacterization of [(3)H]ucb 30889 binding to synaptic vesicle protein 2A in the rat spinal cord. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cSep 2005 |
||
| 300 |
_a70-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xchemistry |
| 650 | 0 | 4 |
_aAzides _xchemistry |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aLevetiracetam |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xmetabolism |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
| 650 | 0 | 4 |
_aPiracetam _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPyrrolidines _xchemistry |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSpinal Cord _xmetabolism |
| 650 | 0 | 4 |
_aSynaptic Vesicles _xmetabolism |
| 700 | 1 | _aGillard, Michel | |
| 700 | 1 | _aVertongen, Pascale | |
| 700 | 1 | _aFuks, Bruno | |
| 700 | 1 | _aChatelain, Pierre | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 520 _gno. 1-3 _gp. 70-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2005.07.029 _zAvailable from publisher's website |
| 999 |
_c15762243 _d15762243 |
||